Localized scleroderma/morphea

International Journal of Dermatology

Volumn 41, Issue 8, 2002, Pages 467-475

  Sehgal, Virendra N ^a   Srivastava, Govind ^b   Aggarwal, Ashok K ^b   Behl, Pran N ^b   Choudhary, Manisha ^b   Bajaj, Promila ^b  

^a Sehgal Nursing Home   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANTIMALARIAL AGENT; BCG VACCINE; BROMOCRIPTINE; CALCIPOTRIOL; CALCITRIOL; CLOFIDINE; DERMATOLOGICAL AGENT; METHOTREXATE; METHOXSALEN; PENICILLAMINE; PHENYTOIN; PSORALEN; SALAZOSULFAPYRIDINE; STEROID; UNCLASSIFIED DRUG; VITAMIN K GROUP;

CHICKENPOX; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DISEASE CLASSIFICATION; ESTHETICS; ETHNIC OR RACIAL ASPECTS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; INCIDENCE; LICHEN SCLEROSUS ET ATROPHICUS; MORPHEA; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PHYSIOTHERAPY; PLASTIC SURGERY; PROSTHESIS; PUVA; SAFETY; SCLERODERMA; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

HUMANS; INCIDENCE; SCLERODERMA, LOCALIZED;

EID: 0036672567     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01469.x     Document Type: Conference Paper

References (97)

1. Scleroderma
2. Connective tissue disorders
3. Scleroderma in diseases of the skin
4. Localised scleroderma - A clinical study of 235 cases
5. The performance of localised scleroderma
6. Childhood-onset scleroderma: Is it different from adult-onset disease
7. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993
8. Racial differences in scleroderma among women in Michigan
9. Classification of morphea (localized scleroderma)
10. Studies on pathogenesis of morphea, vitiligo and acrodermatitis atrophicus by transplantation experiment
11. Koebners' phenomenon, morphea, and viral exanthemas
12. Diagnosis of Lyme disease based on dermatologic manifestation
13. The many faces and phases of borreliosis II
14. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus
15. Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans
16. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America
17. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients
18. Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic, and immunohistochemical observations
19. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A propective study and literature review
20. Localised scleroderma (morphea) and antibody to Borrelia burgdorferi
21. Dermatomyositis
22. Localized scleroderma
23. Morphea
24. Zur frage der systematisierten bandfomigen skeleroderma
25. Development of severe limited scleroderma in complicated Raynaud's phenomenon after limb immobilization: Report of two cases and study of collagen biosynthesis
26. Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda
27. Clinical and histopathological morphea with immunological evidence of LE
28. Scleroderma-like hypodermitis of the buttock due to intramuscular injection of drugs combined with vitamin K1
29. Post-irradiation morphea
30. Morphea-like reaction to D-penicillamine therapy
31. Morphea after bromocriptin therapy
32. Association of HLA antigens with progressive systemic sclerosis and morphea
33. An investigation into the incidence of auto-immune disorders in patients with localized morphoea
34. Generalized morphea and idiopathic thrombocytopenia
35. On histochemistry of scleroderma
36. The effect of collagenase on fixed and unfixed skin lesion of morphea
37. On a fine tissue study of scleroderma
38. Ultrastructural study of skeletal muscle in morphoea
39. Immunohistological studies, with anti-connective tissue and anti-immunoglobulin antisera, of the skin in lupus erythematosus and scleroderma
40. Cellular infiltrates in scleroderma skin
41. Plasma cell panniculitis: A unique clinical and pathological presentation of linear scleroderma
42. Morphea limited to the superficial reticular dermis: An underrecognized histologic phenomenon
43. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus
44. Histological comparison of morphea and lichen sclerosus et atrophicus
45. Disaccharide analysis of skin glycosaminoglycan in localized scleroderma
46. Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea
47. Concomitant unilateral idiopathic, atrophoderma of Pasini and Pierini (IAPP) and morphea. Observations supporting IAPP as a variant of morphea
48. Zosteriform atrophoderma of Pasini and Pierini
49. Self-involuting atrophoderma of the lateral upper arm. A new benign variant of morphea?
50. Rare case of lichen sclerosus et atrophicus associated with morphea
51. Morphea coexisting with lichen sclerosus et atrophicus
52. Lichen sclerosus et atrophicus, bullous morphea, and systemic lupus erythematosus: A case report
53. Bullous morphea: A distinct entity?
54. A tri-linear pattern of scleroderma 'en coup de sabre' following Blaschko's lines
55. Bilateral en coup de sabre - A rare entity
56. Double-lined frontoparietal scleroderma en coup de sabre
57. Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PM)
58. Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines
59. Linear scleroderma in children
60. Restrictive ophthalmopathy associated with linear scleroderma
61. Oral-facial characteristics of circumscribed with linear scleroderma: Case report
62. Localized morphea in children
63. Localized scleroderma
64. Localized scleroderma: Imaging features
65. Scleroderma en coup de sabre with intracranial involvement. A case report
66. Bilateral linear temporoparietal scleroderma en coup de sabre
67. Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea
68. Parry-Romberg syndrome with contralateral and ipsilateral extremity involvement
69. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions?
70. Scleroderma overlap syndromes
71. Scleroderma-like disorders
72. Resolution of solitary morphea profunda associated with generalized vitiligo
73. Guess what? Inflammatory disseminated morphea profunda
74. Solitary morphoea profunda
75. Perforating plate-like osteoma cutis in a man with solitary morphoea profunda
76. Disabling pansclerotic morphea of children
77. PUVA therapy in disabling pansclerotic morphoea of children
78. Treatment of localised scleroderma by UVA1 phototherapy
79. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients
80. Low-dose UVA phototherapy for treatment of localized scleroderma
81. Psoralen UVA therapy for linear and generalized morphea
82. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood
83. Low-dose broadband UVA in morphea using a new method for evaluation
84. Topical photodynamic therapy for localized scleroderma
85. Lesions of the hand and upper limb in children with linear scleroderma. Therapeutic approach in two cases
86. Oral calcitriol as a new therapeutic modality for generalized morphea
87. D-Penicillamine in treatment of scleroderma "en coup de sabre"
88. Low-dose methotrexate in the treatment of widespread morphea
89. Generalized morphea and lichen sclerosus et atrophicus successfully treated with sulphasalazine
90. Topical calcipotriene for morphea/linear scleroderma
91. Repair of coup de sabre, a linear form of scleroderma. Case report
92. Repair of "coup de sabre", a linear form of scleroderma
93. Repair of "coup de sabre" with tissue expander
94. Repair of a large "coup de sabre" with soft-tissue expansion and artificial bone graft
95. Microvascular free-flap correction of severe hemifacial atrophy